Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients
Our findings suggest that the m6A modification influences the tumor microenvironment and that IGF2BP1 acts as an independent predictor of immunotherapy response in LUAD. It may serve as an innovative biomarker for LUAD prognosis and tumor immunity status.
Authors
- Xikun Zhang (ORCID: https://orcid.org/0000-0002-8346-8594)
- Yang Yang (ORCID: https://orcid.org/0000-0002-3842-4744)
- Zhizhao Zhang
- Chen Xue
- Guangyang Bai
Institutions
- Henan University of Science and Technology (CN)
- Shandong Provincial Hospital (CN)
- Qinghai Provincial Peoples Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.3389/fonc.2026.1751029
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00